Belvedere Trading’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Hold
0
410
2024
Q3
Hold
0
357
2024
Q2
Hold
0
352
2023
Q3
Hold
0
381
2023
Q2
Sell
-24,011
Closed -$552K 452
2023
Q1
$552K Buy
+24,011
New +$552K ﹤0.01% 32
2022
Q3
Hold
0
202
2022
Q2
Hold
0
283
2022
Q1
Sell
-11,948
Closed -$350K 333
2021
Q4
$350K Buy
11,948
+763
+7% +$22.4K 0.02% 40
2021
Q3
$337K Buy
+11,185
New +$337K 0.01% 58